Background illustration for clinical trials search

Lung Cancer Clinical Trials

Browse 2,144 lung cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

for
Asthma, Atherosclerosis, Metabolic Syndrome, Insulin Resistance,
Location: Research Triangle Park NC
Sponsor: National Institute of Environmental Health Sciences (NIEHS)

Sex: All

Age: 18 - 70+

Code: NCT01143480

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

Norris ORIEN Total Cancer Care

for
Cancer Risk, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT02970045

Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

for
Primary Extra-cranial Solid Tumor,
Location: Boston MA, New York NY, Atlanta GA, Cincinnati OH,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1 - 21

Code: NCT04928677

Phase 1, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for
Carcinoma, Non-Small Cell Lung
Location: Westbury NY, Fresh Meadows NY, Philadelphia PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06868277

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

for
Patients With Non-Small Cell Lung Cancer
Location: Rimouski, Worcester MA, Norwich CT, Patchogue NY,
Sponsor: OSE Immunotherapeutics

Sex: All

Age: 18+

Code: NCT06472245

Phase 3, Recruiting

A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Location: Montreal, Fort Lauderdale FL, Toronto, Pittsburgh PA,
Sponsor: Bayer

Sex: All

Age: 18+

Code: NCT06452277

Phase 3, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Westbrook ME, Worcester MA, Hartford CT, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

for
Cancer Metastatic, Metastatic Solid Tumor
Location: Paramus NJ
Sponsor: Valley Health System

Sex: All

Age: 18 - 70+

Code: NCT05232409

Phase 1, Recruiting

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

for
Non-small Cell Lung Cancer
Location: Philadelphia PA, Baltimore MD, Lexington KY, Fargo ND,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06731907

Phase 2, Recruiting

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

for
Copd, COPD Exacerbation, COPD Bronchitis, Emphysema or COPD,
Location: Charlestown MA
Sponsor: MGH Institute of Health Professions

Sex: All

Age: 40+

Code: NCT06304207

Recruiting

Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer

for
Liver Metastases, Non-small Cell Lung Cancer
Location: Ann Arbor MI
Sponsor: VA Ann Arbor Healthcare System

Sex: All

Age: 18+

Code: NCT05430009

Phase 1, Recruiting

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for
Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer,
Location: Plantation FL, Ocala FL, Dearborn MI, Troy MI,
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT06281678

Phase 2, Recruiting

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

for
Cancer, Metastatic Cancer, Locally Advanced,
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT06416007

Phase 2, Recruiting

CIBMTR Research Database

for
Autologous Stem Cell Transplantation,
Location: Milwaukee WI, Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01166009

Recruiting

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

for
Cancer
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT01148407

Recruiting

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

for
Papillary Thyroid Cancer, Pediatric Cancer,
Location: Boston MA, Philadelphia PA, Atlanta GA, Memphis TN,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT05024929

Recruiting

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

for
Solid Tumor, Adult, Colorectal Cancer,
Location: Houston TX
Sponsor: Crossignal Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06598007

Phase 1, Phase 2, Recruiting

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

for
Glioma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT01772771

Recruiting

Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer

for
Cancer
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 5+

Code: NCT00760656

Recruiting

What is lung cancer?

Lung cancer starts when cells in the airways or lungs grow out of control. About 229,000 Americans will be diagnosed in 2026. There are two main types: non small cell lung cancer, about 85 percent of cases, and small cell lung cancer, which grows and spreads faster and is treated differently. Smoking causes most cases, but 10 to 20 percent happen in people who never smoked, from causes like radon, air pollution, or genetic changes. Most people are diagnosed around age 70.

Two things changed treatment. First, many lung cancers are driven by a single gene change, and pills that target that specific change can control the cancer for years, so tumors are now routinely tested for these changes before treatment starts. Second, immunotherapy works especially well in lung cancer, and some people with advanced disease are alive and well more than five years later. New targeted drugs kept getting approved through 2025, which is why lung cancer has more recruiting trials than any cancer except breast cancer.

Types of lung cancer clinical trials

Who can participate in lung cancer clinical trials?

What causes lung cancer?

Does vaping cause lung cancer?

The stages of lung cancer, and why they matter for trials

How to enroll in a lung cancer clinical trial